This article has been co-authored by: Dr Tedros Adhanom Ghebreyesus, WHO Director-General; Dr Princess Nono Simelela, Advisor to the Minister of Health, South Africa; Prof Groesbeck Parham, Consultant Gynecologic Oncologist, University of Zambia; Richard Freeman, Executive Officer, WHO; Dr Prebo Barango, WHO Cross-Cutting Specialist for NCDs and Special Initiatives; Claire Kimilu, Consultant, WHO Cervical Cancer Elimination Initiative
For the first time in public health history, the end of a cancer is in sight. We already have the tools to make this possible. With HPV vaccination, screening and timely treatment, cervical cancer could become the first cancer ever eliminated.
Yet each year, more than 600,000 women are diagnosed with cervical cancer and about 280,000 lose their lives. Behind every number is a woman whose life, family and future matter. When a mother dies, her children will be left to grow up without her love, protection and support. These maternal orphans are among the often-invisible victims of cervical cancer, their loss echoing across families, communities and generations.
The disease burden is profoundly unequal. Cervical cancer disproportionately affects women and families in the world's poorest communities, and 19 of the 20 countries with the highest burden are in the World Health Organisation’s African Region. Beyond the physical suffering caused by advanced disease, too many women face stigma, silence and formidable barriers to lifesaving care.
That’s why WHO made a forceful call to action in 2018. Countries have been rising to the challenge. In 2020, even in the midst of the Covid-19 pandemic, WHO Member States adopted a Global Strategy to Accelerate the Elimination of Cervical Cancer. The strategy set ambitious but achievable targets: 90% HPV vaccination coverage for girls, 70% screening coverage for women, and 90% access to treatment for those with precancerous lesions or cancer.
At a time when the world often seems overwhelmed by intractable problems, cervical cancer elimination offers a different story: one of science, solidarity and sustained commitment delivering results.
Progress is accelerating. Australia and Sweden are approaching the historic milestone of eliminating cervical cancer as a public health problem, while Rwanda is demonstrating that similar progress is possible in Africa, with several districts already meeting key WHO elimination targets.
Six years after the strategy's launch, the landscape has changed dramatically. Vaccine supply constraints that once threatened progress have largely been overcome, and there are now more HPV vaccines on the market. Today, 166 countries have introduced HPV vaccination into their national immunisation programmes, including Burundi, Papua New Guinea and Ukraine in the past year alone. India recently rolled out one of the world's largest HPV vaccination campaigns, reaching more than 11 million girls.